atenolol has been researched along with Angina, Stable in 7 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Angina, Stable: Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To comparatively estimate the time course of changes in key metabolic parameters and quality of life (QL) in patients with coronary heart disease during 4-week therapy with atenolol and amlodipine." | 9.17 | [Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. ( Bespalova, LD; Kalyuzhin, VV; Kalyuzhina, EV; Kolesnikov, RN; Pushnikova, EY; Teplyakov, AT, 2013) |
| "To explore possible differential effects between metoprolol and atenolol in patients with coronary artery disease." | 9.16 | Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease. ( Aaberge, L; Ablad, B; Bjurö, T; Gullestad, L; Høglund, L; Kjekshus, E; Mellgård, AJ; Pernow, J; Skårdal, R; Wahlquist, I, 2012) |
| "To comparatively estimate the time course of changes in key metabolic parameters and quality of life (QL) in patients with coronary heart disease during 4-week therapy with atenolol and amlodipine." | 5.17 | [Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. ( Bespalova, LD; Kalyuzhin, VV; Kalyuzhina, EV; Kolesnikov, RN; Pushnikova, EY; Teplyakov, AT, 2013) |
| "To explore possible differential effects between metoprolol and atenolol in patients with coronary artery disease." | 5.16 | Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease. ( Aaberge, L; Ablad, B; Bjurö, T; Gullestad, L; Høglund, L; Kjekshus, E; Mellgård, AJ; Pernow, J; Skårdal, R; Wahlquist, I, 2012) |
| " There were small, nonsignificant differences in the number of adverse events between the two groups (66 in Iva and 73 in Aten, p > 0." | 2.79 | The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris. ( Jia, Y; Jiang, J; Jiang, R; Jing, L; Li, T; Li, X; Li, Y; Liu, S; Lu, Q; Shou, X; Wang, L; Wang, X; Wang, Z; Wei, J; Xia, H; Xie, P; Xing, B; Yang, Z, 2014) |
| "Patients with chronic stable angina pectoris were randomized to treatment with ivabradine (5 to 7." | 2.78 | Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study. ( Kahan, T; Ponikowski, P; Tardif, JC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shavarov, AA | 1 |
| Kiiakbaev, GK | 1 |
| Kobalava, ZhD | 1 |
| Kalyuzhin, VV | 1 |
| Teplyakov, AT | 1 |
| Pushnikova, EY | 1 |
| Bespalova, LD | 1 |
| Kalyuzhina, EV | 1 |
| Kolesnikov, RN | 1 |
| Li, Y | 2 |
| Jing, L | 1 |
| Jiang, J | 1 |
| Wang, Z | 1 |
| Wei, J | 1 |
| Li, X | 1 |
| Wang, L | 1 |
| Xia, H | 1 |
| Li, T | 1 |
| Liu, S | 1 |
| Xing, B | 1 |
| Yang, Z | 1 |
| Lu, Q | 1 |
| Jiang, R | 1 |
| Xie, P | 1 |
| Shou, X | 1 |
| Wang, X | 1 |
| Jia, Y | 1 |
| Oh, PC | 1 |
| Kang, WC | 1 |
| Moon, J | 1 |
| Park, YM | 1 |
| Kim, S | 1 |
| Kim, MG | 1 |
| Lee, K | 1 |
| Ahn, T | 1 |
| Shin, EK | 1 |
| Gullestad, L | 1 |
| Pernow, J | 1 |
| Bjurö, T | 1 |
| Aaberge, L | 1 |
| Skårdal, R | 1 |
| Kjekshus, E | 1 |
| Høglund, L | 1 |
| Mellgård, AJ | 1 |
| Wahlquist, I | 1 |
| Ablad, B | 1 |
| Tardif, JC | 1 |
| Ponikowski, P | 1 |
| Kahan, T | 1 |
| Riccioni, G | 1 |
| Prencipe, G | 1 |
| Benvenuto, A | 1 |
| Masciocco, L | 1 |
| Ventra, S | 1 |
| Rizzo, U | 1 |
| Russi, C | 1 |
| Speziale, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris[NCT02547597] | Phase 4 | 99 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 trials available for atenolol and Angina, Stable
| Article | Year |
|---|---|
[A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris].
Topics: Aged; Angina, Stable; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Drug Therapy, Combination; Fem | 2013 |
[Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Amlodipine; Angina, Stable; Atenolol; Calcium Channel | 2013 |
The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris.
Topics: Adult; Aged; Angina, Stable; Atenolol; Benzazepines; Blood Pressure; China; Double-Blind Method; Exe | 2014 |
Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angina, Stable; Atenolol; Carbazoles; Cardiotonic Agen | 2016 |
Differential effects of metoprolol and atenolol to neuropeptide Y blockade in coronary artery disease.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angina, Stable; Atenolol; Blood Pressure; Coron | 2012 |
Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Double-Blind Method; Drug | 2013 |
Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Atenolol; Benzazepines; Bisoprolol; Carbazoles; C | 2013 |